The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro

The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglisproThe PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro, Published online: 21 November 2017; doi:10.1038/tpj.2017.45

Source: The Pharmacogenomics Journal - November 21, 2017 Category: Drugs & Pharmacology Authors: S Pillai S Duvvuru P Bhatnagar W Foster M Farmen S Shankar C Harris E Bastyr III B Hoogwerf A Haupt Source Type: research